Neuropathological findings in three cases of persistent dyskinesia following phenothiazine medication.
D000328:Adult; D000368:Aged; D001921:Brain / Q000473:pathology*; D001923:Brain Chemistry; D001933:Brain Stem / Q000473:pathology; D002540:Cerebral Cortex / Q000473:pathology; D003300:Copper / Q000032:analysis; D005152:Facial Muscles / Q000187:drug effects; D005260:Female; D005911:Gliosis; D006801:Humans; D007501:Iron / Q000032:analysis; D008055:Lipids / Q000032:analysis; D008410:Masticatory Muscles / Q000187:drug effects*; D009069:Movement Disorders / Q000139:chemically induced* / Q000473:pathology; D010640:Phenothiazines / Q000009:adverse effects*; D013378:Substantia Nigra / Q000473:pathology; D014059:Tongue; D014149:Tranquilizing Agents / Q000009:adverse effects*; D015032:Zinc / Q000032:analysis
D008055:Lipids; D010640:Phenothiazines; D014149:Tranquilizing Agents; D003300:Copper; D007501:Iron; D015032:Zinc